Delivery Order SPE2DB22D1017-SPE2DB25FG7KB
- Not listed
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,570.70 for Pfizer COVID-19 vaccines (2024-25 formulation, 0.9ml) with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order through its...
- The Defense Logistics Agency awarded a delivery order valued at $1,100.15 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9mL) with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction under AmerisourceBergen's broader contract vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (0.9 mL) under contract 4567983925. This firm fixed-price delivery order, issued on April 21, 2025, with an ultimate completion date of May 12, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccine (2024-25 formulation, 0.9 mL, Emergency Use Authorization) with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The U.S. Defense Logistics Agency awarded a $3,141.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9 mL) with an ultimate completion date of August 12, 2025. This non-set-aside competitive award was issued on July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under a firm fixed-price contract with a ceiling value of $1,570.70. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the...
- This delivery order, valued at $1,570.70, was awarded on July 14, 2025, to AmerisourceBergen Drug Corp for the supply of Pfizer COVID-19 vaccine (2024-25 formulation, 0.9mL) under an Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed price, non-set-aside award with an ultimate completion date of August 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child delivery...
- This is a $1,570.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccine doses with a 0.9 mL dosage, to be provided between 2024 and 2025 under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of July 15, 2025 and was awarded on June 23, 2025. This contract is not set aside and...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccine doses. The contract has a ceiling value of $1,570.70 and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG7KBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,570.70 to AmerisourceBergen Drug Corp for Pfizer COVID-19 vaccines (2024-25, 6-month to 4-year formulation, 0.9ML) with a firm fixed price structure. The contract, awarded on July 16, 2025, with an ultimate completion date of August 6, 2025, was competitively awarded with no set-aside designation. Performance will take place at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single purchase under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The Troop Support Medical supply chain relies on AmerisourceBergen as a critical vendor for federal medical procurement, particularly for vaccines and specialized healthcare commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/16/25 |